Moreover, currently available blood p-tau biomarkers appear to have different associations with AD pathology, but a direct comparison of different p-tau variants is hindered by the large heterogeneity in p-tau immunoassays tested in such studies11–13. The gene discussed is MAPT; the disease is Alzheimer disease.